Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e23584
Publisher
Public Library of Science (PLoS)
Online
2011-08-18
DOI
10.1371/journal.pone.0023584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways
- (2017) John P. Cogswell et al. JOURNAL OF ALZHEIMERS DISEASE
- Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia
- (2010) Anatoliy I. Masyuk et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
- (2010) Helen M. Heneghan et al. ANNALS OF SURGERY
- Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
- (2010) M A T Hildebrandt et al. ONCOGENE
- Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests
- (2009) Hovsep S. Melkonyan et al. Annals of the New York Academy of Sciences
- MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1
- (2009) Li-Min Guo et al. FEBS Journal
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
- (2009) Florin M. Selaru et al. HEPATOLOGY
- MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell
- (2009) Tan Hao-Xiang et al. MEDICAL ONCOLOGY
- Exosomes from human saliva as a source of microRNA biomarkers
- (2009) A Michael et al. ORAL DISEASES
- Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
- (2009) Murad Aljiffry et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Detection and Characterization of Placental MicroRNAs in Maternal Plasma
- (2008) S. S.C. Chim et al. CLINICAL CHEMISTRY
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- Down-regulation of the microRNAsmiR-34a,miR-127, andmiR-200bin rat liver during hepatocarcinogenesis induced by a methyl-deficient diet
- (2008) Volodymyr P. Tryndyak et al. MOLECULAR CARCINOGENESIS
- Detection of microRNA Expression in Human Peripheral Blood Microvesicles
- (2008) Melissa Piper Hunter et al. PLoS One
- A microRNA DNA methylation signature for human cancer metastasis
- (2008) A. Lujambio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary
- (2008) Takuya Mishima et al. REPRODUCTION
- Physiology of bile secretion
- (2008) Alejandro Esteller WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice
- (2008) Takashi Tajiri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Epigenetic inactivation of microRNA genehsa-mir-9-1in human breast cancer
- (2007) U Lehmann et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More